Bharat Biotech seeks DCGI approval for intranasal heterologous boosters
The vaccine development data will be submitted to peer-reviewed journals,
Stay updated with breaking news from Restricted Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine development data will be submitted to peer-reviewed journals,
Bharat Biotech has secured approval from CDSCO under Restricted Use in Emergency Situation for its intranasal Covid-19 vaccine, iNCOVACC.
A research published in mBio, an open access journal of the American Society for Microbiology last month showed that a needle-free mucosal bacteriophage-based COVID-19 vaccine is effective against SARS-CoV-2 infection.
Food and Drug Administration t issued warning letters to four companies for illegally selling honey-based products that could pose a significant health risk to consumers due to the presence of active drug ingredients Cialis and Viagra not listed on the product labels.
/PRNewswire/ -- As Nebraska farmers brace for high corn rootworm (CRW) pressure following a major resurgence in the Corn Belt in 2021, Golden Harvest is...